BlackRock’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-83,822
| Closed | -$49.5K | – | 5451 |
|
|
2024
Q4 | $49.5K | Buy |
83,822
+301
| +0.4% | +$178 | ﹤0.01% | 4896 |
|
|
2024
Q3 | $65.9K | Buy |
83,521
+24,011
| +40% | +$18.9K | ﹤0.01% | 4699 |
|
|
2024
Q2 | $75.6K | Buy |
59,510
+22,384
| +60% | +$28.4K | ﹤0.01% | 4718 |
|
|
2024
Q1 | $51.6K | Sell |
37,126
-11,318
| -23% | -$15.7K | ﹤0.01% | 4801 |
|
|
2023
Q4 | $77K | Buy |
48,444
+48,082
| +13,282% | +$76.5K | ﹤0.01% | 4804 |
|
|
2023
Q3 | $514 | Hold |
362
| – | – | ﹤0.01% | 5285 |
|
|
2023
Q2 | $576 | Hold |
362
| – | – | ﹤0.01% | 5335 |
|
|
2023
Q1 | $304 | Hold |
362
| – | – | ﹤0.01% | 5418 |
|
|
2022
Q4 | $514 | Hold |
362
| – | – | ﹤0.01% | 5582 |
|
|
2022
Q3 | $1K | Hold |
362
| – | – | ﹤0.01% | 5687 |
|
|
2022
Q2 | $1K | Sell |
362
-17,841
| -98% | -$49.3K | ﹤0.01% | 5734 |
|
|
2022
Q1 | $58K | Buy |
18,203
+4,352
| +31% | +$13.9K | ﹤0.01% | 5306 |
|
|
2021
Q4 | $51K | Buy |
13,851
+717
| +5% | +$2.64K | ﹤0.01% | 5326 |
|
|
2021
Q3 | $88K | Buy |
13,134
+2,290
| +21% | +$15.3K | ﹤0.01% | 5106 |
|
|
2021
Q2 | $111K | Buy |
+10,844
| New | +$111K | ﹤0.01% | 4948 |
|